FDA

Latest Stories

Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

FDA authorizes a second COVID-19 booster for adults over 50

By Tom Howell Jr. - The Washington Times

Dr. Robert Califf gathers his documents as the Senate Committee on Health, Education, Labor and Pension adjourns a hearing on the nomination of Dr. Califf to be commissioner of the Food and Drug Administration on Capitol Hill in Washington, on Dec. 14, 2021. (AP Photo/Manuel Balce Ceneta, File)

Several GOP votes lift Califf as some Democrats buck Biden’s FDA pick

By Tom Howell Jr. - The Washington Times

A person is injected with her second dose of the Pfizer COVID-19 vaccine at a Dallas County Health and Human Services vaccination site in Dallas, Thursday, Aug. 26, 2021. Federal health regulators on Friday, Feb. 11, 2022 delayed next week's public meeting to review Pfizers COVID-19 vaccine for children under 5, saying they want to see more data. (AP Photo/LM Otero, File)

FDA postpones review of child COVID-19 vaccine

By Tom Howell Jr. - The Washington Times

Dr. Robert Califf gathers his documents as the Senate Committee on Health, Education, Labor and Pension adjourns a hearing on the nomination of Dr. Califf to be commissioner of the Food and Drug Administration on Capitol Hill in Washington, on Dec. 14, 2021. (AP Photo/Manuel Balce Ceneta, File)

FDA’s agenda in limbo as Biden’s nominee stalls in Senate

By Matthew Perrone - Associated Press

Nurse Lydia Holly prepares a child's COVID-19 vaccine dose, on Nov. 3, 2021, at Children's National Hospital in Washington. U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children ages 5 and under while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February. (AP Photo/Carolyn Kaster, File)

Pfizer set to request emergency approval of COVID-19 vaccine for children younger than 5

By Tom Howell Jr. - The Washington Times

A doctor holds a Regeneron monoclonal antibody infusion bag during a news conference Thursday, Aug. 19, 2021 at a hospital in Fort Lauderdale, Fla. On Monday, Jan. 24, 2022, the Food and Drug Administration said COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the dominant omicron variant. (Joe Cavaretta/South Florida Sun-Sentinel via AP) **FILE**

Florida cancels 2,000 monoclonal treatment appointments after FDA move

By Tom Howell Jr. - The Washington Times

A dose of a Pfizer COVID-19 vaccine is prepared at Lurie Children's hospital, Nov. 5, 2021, in Chicago. The omicron-fueled surge that is sending COVID-19 cases rocketing in the U.S. is putting children in the hospital in close to record numbers, and experts lament that most of the youngsters are not vaccinated. (AP Photo/Nam Y. Huh, File)

FDA and its flimsy COVID-19 FOIA dodge falls flat with federal judge

By Cheryl K. Chumley - The Washington Times

Ray Bellia holds up N95 personal protective masks, used by medical and law enforcement professionals, in the warehouse of his Body Armor Outlet store, Wednesday, Dec. 9, 2020, in Salem, N.H. Bellia's store rapidly evolved into one of the nation's 20 largest suppliers of personal protective equipment to states this past spring, according to a nationwide analysis of state purchasing data by The Associated Press. (AP Photo/Charles Krupa)

Calls to upgrade masks intensify as omicron spreads

By Valerie Richardson - The Washington Times

Lucas Kittikamron-Mora, 13, holds a sign in support of COVID-19 vaccinations as he receives his first Pfizer vaccination at the Cook County Public Health Department, May 13, 2021 in Des Plaines, Ill. The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12. Boosters already are recommended for everyone 16 and older, and federal regulators on Monday, Jan. 3, 2022 decided they’re also warranted for 12- to 15-year-olds once enough time has passed since their last dose. (AP Photo/Shafkat Anowar) **FILE**

FDA clears Pfizer COVID booster for ages 12 to 15, shortens wait time for others amid omicron

By Tom Howell Jr. - The Washington Times

This undated photo provided by Merck &amp; Co. shows their new antiviral medication molnupiravir. U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wave of infections driven by the omicron variant. The Food and Drug Administration granted the drug emergency use Thursday, Dec. 23, 2021, for adults with early COVID-19 who face the highest risks of hospitalization. (Merck &amp; Co. via AP, File)

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19

By Matthew Perrone - Associated Press

This image provided by Pfizer shows its COVID-19 pill. Drugmaker Pfizer said Tuesday, Nov. 16, 2021, it is submitting its experimental pill for U.S. authorization, setting the stage for a likely launch in coming weeks. (Pfizer via AP)

FDA authorizes Pfizer COVID-19 pill for emergency use

By Tom Howell Jr. - The Washington Times

This Sept. 22, 2010 file photo shows bottles of abortion pills at a clinic in Des Moines, Iowa. The Food and Drug Administration on Thursday, Dec. 16, 2021 loosened some restrictions on the pill mifepristone, allowing it to be dispensed by more pharmacies. (AP Photo/Charlie Neibergall, file)

U.S. regulators lift in-person restrictions on abortion pill

By Matthew Perrone - Associated Press

Food and Drug Administration (FDA) Commissioner Dr. Robert Califf speaks at a news conference in Washington, May 5, 2016. President Joe Biden is nominating Califf to again lead the regulatory agency. (AP Photo/Andrew Harnik) **FILE**

FDA pick Robert Califf pledges to make COVID-19 task ‘No. 1’

By Tom Howell Jr. - The Washington Times

James Robson, a biomedical engineering graduate student, holds a swab and specimen vial in the new COVID-19, on-campus testing lab, Thursday, July 23, 2020, at Boston University in Boston. The United States has improved its surveillance system for tracking new coronavirus variants such as omicron, boosting its capacity by tens of thousands of samples since early 2021. (AP Photo/Charles Krupa) **FiLE**

FDA to the public: We will be nimble in response to omicron

By Tom Howell Jr. - The Washington Times

FILE- In this Dec. 10, 2020, file photo, a sign is displayed for the Food and Drug Administration in Silver Spring, Md. After nearly nine months of searching, President Joe Biden says he’s close to naming his choice to lead the FDA, which oversees vaccines, drugs and tests. (AP Photo/Manuel Balce Ceneta, File)

Some Old Spice and Secret deodorants and sprays recalled

By Shen Wu Tan - The Washington Times

In this Aug. 14, 2018, photo, a doctor looks at PET brain scans in Phoenix. (AP Photo/Matt York) **FILE**

One-third of Alzheimer’s patients using approved drug see brain swelling: study

By Shen Wu Tan - The Washington Times

Maryland Gov. Larry Hogan urges all eligible state residents, especially those with an underlying health condition or comorbidity, to get a COVID-19 vaccine booster shot as soon as possible, during a news conference, Monday, Oct. 25, 2021, in Annapolis, Md. (AP Photo/Brian Witte) **FILE**

Maryland expands eligibility for booster shots to all adults

By Shen Wu Tan - The Washington Times

A syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pa., on Sept. 14, 2021. U.S. regulators have opened up COVID-19 booster shots to all and more adults, Friday, Nov. 19, letting them choose another dose of either the Pfizer or Moderna vaccine. (AP Photo/Matt Rourke, File)

FDA authorizes Pfizer-BioNTech and Moderna COVID-19 boosters for all adults

By Tom Howell Jr. - The Washington Times

In this Nov. 17, 2015, file photo, Dr. Robert Califf, President Obama's then-nominee to lead the Food and Drug Administration (FDA), testifies on Capitol Hill in Washington. The Senate confirmed Califf to be commissioner of the FDA. (AP Photo/Pablo Martinez Monsivais, File)

Biden nominates Robert Califf to lead the FDA once more

By Jeff Mordock - The Washington Times

A health care worker receives a Pfizer COVID-19 booster shot at Jackson Memorial Hospital Tuesday, Oct. 5, 2021, in Miami. (AP Photo/Lynne Sladky) ** FILE **

Pfizer’s booster request sets up a pivotal decision for FDA

By Tom Howell Jr. - The Washington Times